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Mean centeringAbstract Different sensitive and selective spectrophotometric methods for the determination of
oﬂoxacin and dexamethasone in their binary mixture were presented. Oﬂoxacin was determined
simply by zero order at its kmax 293.4 nm in a linear range of 1.5–12 lg mL
1 with mean percentage
recovery of 100.07 ± 0.66% without any interference of dexamethasone even in low or high con-
centrations. Dexamethasone was determined by ﬁrst derivative of ratio spectra 1DD at 266.5 nm,
ratio subtraction and mean centering at 243 nm with methods in a linear range of 2.5–27.5 lg mL1
with mean percentage recoveries of 100.09 ± 0.70%, 100.00 ± 0.72% and 99.92 ± 0.62, respec-
tively. These methods were applied to the analysis of pharmaceutical dosage form and bulk powder
where good recoveries were obtained. The proposed methods were validated according to USP
guidelines.
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Oﬂoxacin (Oﬂox., Fig. 1) (±)-9-ﬂuoro-2,3-dihydro-3-methyl-
10-(4-methyl-L-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-
1,4-benzoxazine-6-carboxylic acid)1 is a ﬂuoroquinolone0 548 6038; fax: +20 202 491
hoo.com (G.M. Elsayed).
aculty of Pharmacy, Cairo
g by Elsevier
ng by Elsevier B.V. on behalf of F
://dx.doi.org/10.1016/j.bfopcu.201antibacterial agent, which is highly active against both
Gram-positive and Gram-negative bacteria. It is also active
against mycoplasma, chlamydia and legionella.2
The mechanism of the bactericidal effect of Oﬂox. is based
on the inhibition of the DNA gyraze of the bacteria, the
enzyme that produces a negative supercoil in DNA and thus
permits transcription and replication.3
Several methods are available for analysis of Oﬂox. such as
high-performance liquid chromatography,4–8 capillary electro-
phoresis,9 chemiluminescence10 and chemometry.11
Dexamethasone (Dexa. Fig 2) [9-Fluoro-11b,17,21-
trihydroxy-16a-methylpregna-1,4-diene-3,20-dione]1, a potent
synthetic corticosteroid with anti-inﬂammatory and
immunosuppressive properties, is frequently used as anaculty of Pharmacy, Cairo University.
3.04.004
Figure 2 Structural formula for dexamethasone (MW= 392.47).
Figure 1 Structural formula for oﬂoxacin (MW= 361.38).
176 M. Nebsen et al.anti-inﬂammatory agent.12 It has been widely used to treat
inﬂammation, allergy and diseases related to adrenal cortex
insufﬁciency.
Several methods had been reported in the literature describ-
ing the analysis of Dexa. including LC,13–17 spectrophotome-
try,18 TLC chromatography19 and voltametry.20
Dexa. was determined with Oﬂox. in their binary mixture
by RF HPLC21 or in their ternary mixture with ephedrine by
microemulsion LC.22
The aim of this study was to develop and validate spectro-
photometric methods for the determination of Oﬂox. and
Dexa. The methods were validated by using the guidelines of
USP.1
2. Experimental
2.1. Instrumentation
Spectrophotometric measurements were carried out using a
double beam UV visible spectrophotometer, Schimadzu Japan,
model 1601 PC, connected to IBM compatible computer and
HP 800 ink Jet printer, the bundle software was a UV PC per-
sonal spectroscopy software version 3.7. The spectral band
width was 0.2 nm and wavelength scanning speed was
2800 nm min1.2.2. Chemicals and reagents
Oﬂox. standard material was kindly supplied by EL Nile com-
pany, Egypt. Its purity was checked in our laboratory accord-
ing to the USP HPLC method1 and was found to be
99.98 ± 0.73%. Dexa. standard material was kindly supplied
by EIPICO Company, Egypt. Its purity was checked in our
laboratory according to USP HPLC method1 and was found
to be 100.30 ± 1.38%. Market sample of Dexaﬂox eye drops
was manufactured by Gamgom pharma, Saudi Arabia, each
1 ml claimed to contain 3 mg Oﬂox. and 1 mg Dexa., batch
number KC 082 was purchased from the local market.
All reagents and solvents used were of analytical grade. 3%
of 0.1 N HCl in methanol was used as a reagent for the prep-
aration of standard solutions.
2.3. Standard stock and working solutions
Oﬂox. standard stock solution: 0.25 mg mL1 in 3% of 0.1 N
HCl/methanol reagent.
Oﬂox. standard working solution: 0.1 mg mL1 in 3% of
0.1 N HCl/methanol reagent.
Dexa. standard stock solution: 0.25 mg mL1 in 3% of
0.1 N HCl/methanol reagent.
Dexa. standard working solution: 0.1 mg mL1 in 3% of
0.1 N HCl/methanol reagent.
2.4. Procedures
2.4.1. Spectral characteristics of oﬂoxacin and dexamethasone
The zero order absorption spectra of 9, 12 lg of Oﬂox. and 2.5,
27.5 lg of Dexa. solutions were recorded against 3% of 0.1 N
HCl/methanol reagent as a blank over the range of 200–
400 nm.
2.4.2. Construction of calibration curves
Aliquots equivalent to 15–120 lg mL1 Oﬂox. and 25–
275 lg mL1 Dexa. are accurately transferred from their stan-
dard working solutions (0.1 mg/mL) into two separate series of
10-ml volumetric ﬂasks then completed to volume with 3% of
0.1 N HCl/methanol reagent. The spectra of the prepared stan-
dard solutions are scanned from 200 to 400 nm and stored in
the computer.
2.4.2.1. For zero order method. The content of Oﬂox. was
determined from the measurements of its absorbance of zero
order spectra at kmax 293.4 nm and plotted against their corre-
sponding concentrations. The same procedure was used to
determine the content of Oﬂox. in the laboratory prepared
mixtures and in pharmaceutical formulations.
2.4.2.2. For ﬁrst derivative of ratio spectrophotometric method.
The computer stored spectra of Dexa. were divided by the pre-
viously stored spectrum of Oﬂox. of concentration 12 lg ml1
and the ﬁrst derivative of the ratio spectra were obtained with
Dk= 4 nm and a scaling factor of ten. The content of Dexa.
was calculated from the measurements of the amplitude of
the ﬁrst derivative peak of (Dexa/Oﬂox) at 266.5 nm and plot-
ted against their corresponding concentrations. The same pro-
cedure was used to determine the content of Dexa. in the
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formulations.
2.4.2.3. For ratio subtraction method. The content of Dexa. was
calculated from the measurements at kmax 240 nm and plotted
against their corresponding concentrations then the regression
equation was computed.
For the determination of Dexa. in laboratory prepared mix-
tures, different ratios of Dexa. and Oﬂox. were prepared then
the prepared standard solutions were scanned from 200 to
400 nm and stored in the computer. The same procedure was
used to determine the content of Dexa. in the pharmaceutical
formulation.
2.4.2.4. For mean centering method. The computer stored spec-
tra of Dexa. were divided by the previously stored spectrum of
Oﬂox. of concentration 12 lg mL1 then the obtained ratio
spectra were mean centered. The content of Dexa. was calcu-
lated from the measurements of the mean centered peak of
(Dexa/Oﬂox) at 243 nm and plotted against their correspond-
ing concentrations. The same procedure was used to determine
the content of Dexa. in the laboratory prepared mixtures and
in pharmaceutical formulations.
2.4.3. Analysis of Oﬂox. and Dexa. laboratory prepared
mixtures
Into a series of 10-ml volumetric ﬂasks aliquots of Oﬂox. and
Dexa. were accurately transferred from their corresponding
working solutions (0.1 mg mL1) each. Then the volumes were
completed with blank reagents each one separately to prepare
mixtures containing different ratios of the two drugs. The zero
order spectrum of each laboratory prepared mixture was re-
corded against blank reagents then stored in the computer.
2.4.3.1. For Oﬂox. The absorbance of the zero order spectra at
293.4 nm was recorded, then the concentrations of the intact(d) 
(c) 
Abs. 
Wav
Figure 3 Zero order absorption spectra of Oﬂox. (a) 12, (b) 9 lg ml
in methanol reagent as blank.drug were calculated from their corresponding regression
equation.
2.4.3.2. For Dexa. (1DD). The obtained spectra were then di-
vided by the spectrum of 12 lg ml1 of Oﬂox. The peak ampli-
tudes of the ﬁrst derivative of ratio spectra 1DD at 266.5 were
measured then the concentrations of the intact drug were cal-
culated from their corresponding regression equation.
2.4.3.3. For Dexa. (Ratio subtraction). The obtained spectra
were then divided by the spectrum of 9 lg ml1 of Oﬂox. to
obtain new division spectra. The absorbance in the plateau re-
gion at 300–320 nm giving a constant value was subtracted
from the division spectra, the obtained curves were multiplied
by the spectrum of 9 lg/ml Oﬂox. The obtained curves can be
used for direct determination of Dexa. at 240 nm and the con-
centrations were calculated from the corresponding regression
equation.
2.4.3.4. For Dexa. (mean cetering). The obtained spectra were
then divided by the spectrum of 12 lg ml1 of Oﬂox. The mean
centered values of ratio spectra at 243 nm were measured Then
the concentrations of the intact drug were calculated from
their corresponding regression equation.
2.4.4. Analysis of Oﬂox. and Dexa. in Dexaﬂox eye drops
FromDexaﬂox eye drops bottle (each 1 ml contains 1 mgDexa.
and 3 mg Oﬂox.), a volume 1 ml was transferred quantitatively
into 10-ml volumetric ﬂask, the volume was then completed to
mark with a blank reagent. Aliquots were transferred into 10-
ml volumetric ﬂasks, the volume was then completed to mark
with a blank reagent then analyzed as described under analysis
of laboratory prepared mixtures. The concentrations were cal-
culated from the corresponding regression equations.
Moreover, standard addition technique was applied to as-
sess the validity of the method.(b)
(a)
e length (nm) 
1 (__) and Dexa. (c) 27.5, (d) 2.5 lg ml1 (—) using 3% 0.1 N HCl
(a)
(c)
Abs. 
Wave length (nm) 
(b)
Figure 4 Zero order spectra of laboratory prepared mixtures of Oﬂox.: Dexa., respectively: (a) 12 lg ml1 : 4 lg ml1, (b) 9 lg ml1 :
15 lg ml1 , (c) 7.5 lg ml1 : 7.5 lg ml1.
Abs. 
Wave length (nm) 
Figure 5 Ratio spectra of Dexa. 2.5–27.5 lg ml1 using Oﬂox. 12 lg ml1 as a divisor and 3% 0.1 N HCl in methanol reagent as blank.
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The primary goal of this study was to develop and validate spec-
trophotometric methods that could assay Dexa. and Oﬂox. in
their binary mixture with sufﬁcient selectivity and sensitivity
either in bulk powder or in pharmaceutical preparation.3.1. Zero order spectrophotometric method
Spectral characteristics of Oﬂox. and Dexa. are shown in
Fig. 3. Oﬂox. can be directly determined by zero order spectro-
photometry but direct analysis of Dexa. in the presence of
Oﬂox. cannot be performed.
266.5nm
Abs. 
Wave length (nm) 
Figure 6 First derivative of ratio spectra of Dexa. 2.5–27.5 lg ml1 using Oﬂox. 12 lg ml1 as a divisor and 3% 0.1 N HCl in methanol
reagent as blank.
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bance and the concentration of Oﬂox. at its kmax 293.4 nm
and regression equation was calculated and found to be:
Abs: ¼ 0:0963 Cþ 0:0078 r ¼ 1
Direct determination of Oﬂox in laboratory prepared mix-
tures was applied (Fig. 4).
3.2. First derivative ratio spectrophotometric method (1DD)
Derivative ratio spectrophotometric technique was widely used
for resolving either binary23,24 or tertiary25,26 mixtures. The
main advantage of the ratio spectra derivative spectrophotom-
etry is the chance of doing easy measurements in correspon-
dence of peaks so it permits the use of the wavelength of
highest value of analytical signals (a maximum or a minimum).
It is necessary to study and to optimize the following parame-
ters: concentration of the standard spectrum used as divisor,
Dk to obtain the ﬁrst derivative, smoothing function and
zero-crossing wavelengths.26
Dexa. was quantiﬁed in the presence of Oﬂox. by 1DD. This
method resulted in a suitable regression equation for Dexa. A
correct choice of standard divisor and working wavelength are
of capital importance.
Hence, the method was tested with various divisor concen-
trations. In measurements the spectrum of 12 lg ml1 of
Oﬂox. was used as a standard divisor for the determination
of Dexa. (Fig. 5). Even the presence of more than one peak
in the obtained derivatized spectrum but only that at
k= 266.5 nm gave reproducible results (Fig. 6). This assured
the best compromise in terms of sensitivity, repeatability
and signal to noise ratio. A linear relationship was found
between the peak amplitudes and the concentration of
Dexa. at 266.5 nm in the range of 2.5–27.5 lg ml1 fromwhich the linear regression equation was calculated and found
to be:
Peak amplitude ¼ 0:0626 Cþ 0:0004 r ¼ 0:999953.3. Ratio subtraction method
The ratio subtraction technique27,28 starts by scanning zero or-
der spectra of the prepared standard solutions of Dexa., then
the linearity is checked between absorbance at the selected
wavelength of 240 nm and the corresponding concentration
of Dexa.
The method is successfully used for the determination of
Dexa. in its binary mixture where the spectrum of Oﬂox. is
more extended Fig. 3, the zero order absorption spectra of
the laboratory-prepared mixtures (Oﬂox. and Dexa.) were
scanned (Fig. 4), dividing them by a carefully chosen concen-
tration of standard Oﬂox. (9 lg/mL) as a divisor producing
new ratio spectra which represent Dexa./Oﬂox. + constant
as shown in Fig. 7, then subtraction of the values of these con-
stants Dexa./Oﬂox. in the plateau region (300–320 nm) as
shown in Fig. 8, followed by multiplication of the obtained
spectra by the divisor Oﬂox. (9 lg/mL) as shown in Fig. 9. Fi-
nally, the original spectra of Dexa. could be obtained (Fig. 9)
which are used for the direct determination of Dexa. at 240 nm
and calculation of the concentration from the corresponding
regression equation obtained by plotting the absorbance values
of the zero order curves of Dexa. at 240 nm against the corre-
sponding concentrations.
The computed regression equation was found to be:
Abs: ¼ 0:0395 Cþ 0:0028 r ¼ 0:99995
Oﬂox. can be determined directly from its zero order spec-
tra as mentioned before in 3.1.
Abs. 
Wave length (nm) 
Figure 8 Ratio spectra of laboratory prepared mixtures of Dexa. and Oﬂox. using 9 lg ml1 Oﬂox. as a divisor. After subtraction of the
constant.
constant
Abs. 
Wave length (nm) 
Figure 7 Ratio spectra of laboratory prepared mixtures of Dexa. and Oﬂox. using 9 lg ml1 Oﬂox. as a divisor.
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For further improvement of the selectivity to resolve the over-
lap present between Oﬂox. and Dexa., a simple method is ap-
plied which is based on the mean centering of ratio spectra. It
eliminates the derivatization step and therefore the signal-to-
noise ratio is enhanced.29,30As the appropriate divisor was chosen, then the obtained
ratio spectra is mean centered, so upon division; the Oﬂox. be-
comes constant then the mean center of constant equals zero
so the Dexa. concentration is obtained without any interfering
of Oﬂox.28
Mean centering method is applied to quantitatively
determineDexa. in its laboratory preparedmixtures and in phar-
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Figure 10 Mean centered ratio spectra of Dexa. (2.5–27.5 lg ml1).
(a) 
(b) 
(c) 
Abs. 
Wave length (nm) 
Figure 9 The zero order absorption spectra of Dexa. (a) 15 lg ml1, (b) 7.5 lg ml1, (c) 4 lg ml1 obtained by the proposed ratio
subtraction method for the analysis of laboratory prepared mixtures after multiplication by the divisor 9 lg ml1 Oﬂox.
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divided by the absorption spectrum of 12 lg/ml Oﬂox. (Fig. 5).
The obtained ratio spectra aremean centered and the concentra-
tions ofDexa. determined bymeasuring the amplitude at 243 nm
(Fig. 10). The linear regression equation is found to be:
Mean centering value ¼ 0:0823 Cþ 0:0097 r ¼ 0:99995
The choice of divisor is different from one method to an-
other, which attributed to optimization between increasing
the sensitivity of the method by choosing smaller divisor and
the produced noise which affects the reproducibility of the
obtained results.4. Method validation
Validation was done according to USP guidelines.1
4.1. Linearity and range
The linearity of the methods was evaluated by analyzing eight
concentrations of Oﬂox. and six concentrations of Dexa., Each
concentration was repeated three times. The assay was per-
formed according to the experimental conditions previously
mentioned. The range and linear equations are summarized
in Table 1.
Table 2 Speciﬁcity of the proposed spectrophotometric methods for determination of Oﬂox. and Dexa. in laboratory prepared
mixtures.
Ratio Concentration (lg ml1) Oﬂox Dexa
Oﬂox. Dexa. Zero order
method at 293.4 nm
Derivative ratio
method at 266.5 nm
Ratio subtraction
method at 240 nm
Mean centering
method at 243 nm
Recovery% Recovery% Recovery% Recovery%
3:1 12 4 100.58 100.50 100.50
1:1 7.5 7.5 101.32 99.07 99.07 103.01
3:5 9 15 99.67 99.87 99.87 98.72
1:5 3 15 101.30 100.73 100.73 100.65
1:2 7.5 15 101.99 101.00 101.00 99.99
Mean 100.97 100.23 100.23 100.59
SD 0.88 0.77 0.77 1.80
RSD% 0.87 0.77 0.77 1.80
Table 1 Assay validation parameters of the proposed spectrophotometric methods for the determination of pure Oﬂox. and Dexa.
Parameters Oﬂox Dexa
Zero order First derivative ratio Ratio subtraction Mean centering
Linearity range
(lg ml1) 1.5–12 2.5–27.5 2.5–27.5 2.5–27.5
Accuracy
Mean + SD 100.07 ± 0.66 100.09 ± 0.70 100.00 ± 0.72 99.92 ± 0.62
Precision
Repeatability a 100.44 ± 1.24 99.74 ± 0.805 99.60 ± 0.74 100.07 ± 1.23
Reproducibility b 99.97 ± 1.43 100.12 ± 1.152 100.08 ± 0.94 100.59 ± 0.94
Regression
Slope 0.0963 0.0626 0.0395 0.0823
SE of slope 0.0002 0.0003 0.0020 0.0003
Intercept 0.0078 0.0004 0.0028 0.0097
SE of intercept 0.0017 0.0063 0.0034 0.0055
Correlation coeﬃcient 1 0.99995 0.99995 0.99995
a Repeatability (n= 3), average of three concentrations (4.5, 6, and 7.5 lg ml1) for Oﬂox. and (12.5, 17.5, and 22.5 lg ml1) for Dexa.
repeated three times within the day.
b Reproducibility (n= 3), average of three concentrations (4.5, 6, and 7.5 lg ml1) for Oﬂox. and (12.5, 17.5, and 22.5 lg ml1) for Dexa.
repeated three times in three successive days.
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The accuracy of the results was checked by applying the pro-
posed methods for the determination of different samples of
Oﬂox. and Dexa. The concentrations were obtained from the
corresponding regression equations. From which the percent-
age recoveries were calculated with mean percentage recovery
shown in Table 1.
Accuracy of the methods was further assured by the use of
the standard addition technique, it was performed by the addi-
tion of known amounts of pure Oﬂox. andDexa. to known con-
centrations of the pharmaceutical preparation, the resulting
mixtures were assayed, and the results obtained were compared
with the expected results Table 2. The good recoveries of stan-
dard addition technique suggested good accuracy of the pro-
posed methods.
4.3. Precision
4.3.1. Repeatability
Three concentrations of Oﬂox. (4.5, 6, 7.5 lg mL1) and Dexa.
(12.5, 17.5, 22.5 lg mL1) were analyzed three times intra-dailyusing the proposed methods. The relative standard deviations
were calculated Table 1.4.3.2. Reproducibility
The previous procedures were repeated inter-daily on three dif-
ferent days for the analysis of the three chosen concentrations.
The relative standard deviations were calculated Table 1.
4.4. Speciﬁcity
Speciﬁcity of the methods was achieved by the analysis of dif-
ferent laboratory prepared mixtures of Oﬂox. and Dexa. with-
in the linearity range. Satisfactory results are shown in Table 2.
4.5. Robustness
The linearity concentrations of both Oﬂox and Dexa were pre-
pared using 2%, 3%, 5% 0.1 N HCl/methanol and analyzed
using the proposed methods. The relative standard deviations
were found to be below 2.0% and the methods proved to be
robust.
Table 4 Statistical comparison between the results obtained by applying the proposed spectrophotometric methods and USP HPLC
method (1) for the determination of pure sample of Oﬂox., USP HPLC method (1) for determination of pure sample of Dexa.
Values Oﬂoxacin Dexamethasone
Zero order
method
Oﬃcial HPLC
methoda
Derivative ratio
method
Ratio subtraction
method
Mean centering
method
Oﬃcial HPLC
methodb
Mean 100.07 99.98 100.09 100.00 99.92 100.30
SD 0.66 0.73 0.70 0.77 0.62 1.37
RSD% 0.66 0.73 0.70 0.77 0.62 1.37
Variance 0.44 0.53 0.49 0.59 0.38 1.88
n 8 5 6 6 6 6
t-testc 0.23 (2.201)* 0.33 (2.228)* 0.47 (2.228)* 0.62 (2.228)*
F-value c 1.22 (4.12) 3.83 (5.05)* 3.17 (5.05)* 4.88 (5.05)*
a Perfectsil Target ODS-3 column using a mobile phase consisting of sodium dodecyl sulphate0.24%: acetonitrile: glacial acetic acid (58:40:2
by volume).
b Perfectsil Target ODS-3 column using a mobile phase consisting of water: acetonitril (60:40 v/v).
c The values in the parenthesis are the corresponding theoretical values of t and F at (P= 0.05).
Table 3 Quantitative determination of Oﬂox. and Dexa. in Dexaﬂox eye drops (each 1 mL claimed to contain 1 mg Dexa and 3 mg
Oﬂox) by the proposed spectrophotometric methods and the application of standard addition technique.
Pharmaceutical formulation Recovery % a Standard addition
Dexaﬂox eye drops B.N KC082 Taken (lg mL1) Added (lg mL1) Recovery %
Oﬂox.
Zero order
97.89% 4.5 3.00 101.00
4.50 101.11
6.00 98.33
Mean 100.15
SD 1.57
Dexa.
1DD
105.50% 4 2.50 100.40
4.00 99.85
7.50 99.46
Mean 99.90
SD 0.47
Dexa.
Ratio subtraction
105.00% 4 2.50 100.00
4.00 99.00
7.50 100.67
Mean 99.89
SD 0.84
Dexa.
Mean centering
104.99% 4 4.00 99.42
7.50 101.34
Mean 100.38
SD 1.35
a Average of at least four determinations.
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The proposed methods were applied for the determination
of Oﬂox. and Dexa.in their combined pharmaceutical
formulation in Dexaﬂox eye drops that indicates high
accuracy for the determination of the studied drugs as shown
in Table 3.
6. Statistical analysis
Results obtained by the proposed procedures for the
determination of pure samples of Oﬂox. and Dexa. are statis-
tically compared to those obtained by the ofﬁcial methods.1
The results showed no signiﬁcant differences between them
Table 4.These proposed methods have the advantages of time sav-
ing, simple software program used, no need of expensive sol-
vents compared with their ofﬁcial HPLC methods.
7. Conclusion
The binary Oﬂox. and Dexa. mixture is easily determined by
the proposed simple, accurate and reproducible spectrophoto-
metric methods where Oﬂox. is determined in its zero order
without any interference of Dexa., the interference of Oﬂox.
with the spectrum of Dexa. was overcome by applying ﬁrst
derivative of ratio spectra 1DD, ratio subtraction and mean
centering methods. These reproducible quantitative analysis
methods can be used for the determination of Oﬂox. and Dexa.
in pure bulk powder and in pharmaceutical eye drops and are
184 M. Nebsen et al.also suitable for quality control laboratories where economy
and time are essential.
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